Previous Article | Next Article ![]()
Mol Cell Biol, July 1998, p. 4053-4069, Vol. 18, No. 7
Department of Biology, Yale University, New
Haven, Connecticut 06520-8103
Received 4 November 1997/Returned for modification 22 December
1997/Accepted 7 April 1998
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Spa2p Interacts with Cell Polarity Proteins and
Signaling Components Involved in Yeast Cell Morphogenesis
SUMMARY
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
The yeast protein Spa2p localizes to growth sites and is important
for polarized morphogenesis during budding, mating, and pseudohyphal
growth. To better understand the role of Spa2p in polarized growth, we
analyzed regions of the protein important for its function and proteins
that interact with Spa2p. Spa2p interacts with Pea2p and Bud6p (Aip3p)
as determined by the two-hybrid system; all of these proteins exhibit
similar localization patterns, and spa2
,
pea2
, and bud6
mutants display similar
phenotypes, suggesting that these three proteins are involved in the
same biological processes. Coimmunoprecipitation experiments
demonstrate that Spa2p and Pea2p are tightly associated with each other
in vivo. Velocity sedimentation experiments suggest that a significant portion of Spa2p, Pea2p, and Bud6p cosediment, raising the possibility that these proteins form a large, 12S multiprotein complex. Bud6p has
been shown previously to interact with actin, suggesting that the 12S
complex functions to regulate the actin cytoskeleton. Deletion analysis
revealed that multiple regions of Spa2p are involved in its
localization to growth sites. One of the regions involved in Spa2p
stability and localization interacts with Pea2p; this region contains a
conserved domain, SHD-II. Although a portion of Spa2p is sufficient for
localization of itself and Pea2p to growth sites, only the full-length
protein is capable of complementing spa2 mutant defects,
suggesting that other regions are required for Spa2p function. By using
the two-hybrid system, Spa2p and Bud6p were also found to interact with
components of two mitogen-activated protein kinase (MAPK) pathways
important for polarized cell growth. Spa2p interacts with Ste11p (MAPK
kinase [MEK] kinase) and Ste7p (MEK) of the mating signaling pathway
as well as with the MEKs Mkk1p and Mkk2p of the Slt2p (Mpk1p) MAPK
pathway; for both Mkk1p and Ste7p, the Spa2p-interacting region was
mapped to the N-terminal putative regulatory domain. Bud6p interacts
with Ste11p. The MEK-interacting region of Spa2p corresponds to the
highly conserved SHD-I domain, which is shown to be important for
mating and MAPK signaling. spa2 mutants exhibit reduced
levels of pheromone signaling and an elevated level of Slt2p kinase
activity. We thus propose that Spa2p, Pea2p, and Bud6p function
together, perhaps as a complex, to promote polarized morphogenesis
through regulation of the actin cytoskeleton and signaling pathways.
INTRODUCTION
|
|
|---|
In both unicellular and multicellular organisms, polarized cell growth is crucial for the formation of precise cell morphologies that allow cells to carry out their specialized functions (17, 19, 67, 72). For example, the development of neurites enables nerve cells to carry out sensory transduction (20), formation of microvilli enables epithelial cells to absorb nutrients (56), and growth of pollen tubes in the styles of flowers facilitates plant fertilization (6). Although the cytological events involved in polarized cell growth have been well studied, the molecular mechanisms involved in this process are not well understood.
The budding yeast Saccharomyces cerevisiae undergoes polarized cell growth in several stages of its life cycle (17, 19, 67, 72). Polarized growth is prominent during budding in vegetative and pseudohyphal growth and during projection formation in the mating response. Polarized growth in a vegetative cell begins in late G1, when a bud emerges from a specific site dictated by the mating-type locus and the pedigree of the cell (12, 28, 36, 70, 80). Cell growth occurs initially at the tip of the bud (apical growth) and then continues isotropically as the bud enlarges (47). Finally, just prior to cytokinesis, new cell wall and membrane deposition occurs at the mother-bud neck (47). When limited for nitrogen sources, yeast cells also undergo budding but adopt an elongated morphology and form chains of connected cells called pseudohyphae, which allow cells to spread across a surface to gain access to nutrients (31, 75). During mating, haploid cells respond to pheromone from cells of the opposite mating type and form projections toward their mating partners (82); these projections are important for cell fusion (30, 87).
Polarized cell growth in yeast is a complex process that involves the polarized organization of the actin cytoskeleton (19), the coordinated function of many polarity proteins (67, 72), and the regulation of signal transduction cascades (35, 45). The actin cytoskeleton appears as distinct structures during polarized cell growth (1, 41). Cortical actin patches are concentrated at sites of polarized growth, and actin cables run parallel to the polarity axis (the mother-bud axis during budding and longitudinal to the projection during mating). The actin cytoskeleton is thought to direct secretory vesicles containing growth components (e.g., cell wall and plasma membrane) to growth sites (4, 58, 60).
Many components that influence cell polarity localize to sites of
polarized growth. The yeast protein Spa2p localizes to growth sites and
is important for polarized morphogenesis (14, 30, 57, 71, 80, 81,
92). Spa2p can be found at the incipient bud sites of unbudded
cells, the bud tips of small budded cells, the necks of cells
undergoing cytokinesis, and the projection tips of mating cells.
spa2
cells are rounder than wild-type cells and are
defective in bud site selection in diploid cells, cytokinesis, projection formation during mating, and pseudohyphal growth. Spa2p is a
large protein of 1,466 amino acids with several domains (30, 71), including a predicted coiled-coil region, a domain with 25 9-amino-acid repeats, and five regions that are conserved with those of
a related yeast protein, Sph1p (3, 71). These five domains
are named SHD-I to -V (SHD stands for Spa2p homology domain). The
N-terminal SHD-I is also present in proteins from a wide variety of
eukaryotes, and approximately half of SHD-II is predicted to be coiled
coil (71). How these domains contribute to the function of
Spa2p is not clear.
Pea2p and Bud6p (Aip3p) exhibit many similarities to Spa2p (2,
86). These proteins localize to growth sites in a fashion similar
to that of Spa2p, and diploid pea2
and bud6
mutants are defective in bud site selection (86, 93). Like
spa2
cells, pea2
mutants are defective in
projection formation and pseudohyphal growth (14, 57);
bud6 mutants form round cells and are defective in
cytokinesis (2, 93). Pea2p and Bud6p are smaller than Spa2p
(420 and 788 amino acids, respectively), and each has a predicted
coiled-coil domain (2, 86). Spa2p fails to localize in
pea2
mutants, and Pea2p is not stably produced in
spa2
mutants, raising the possibility that these proteins
might interact (86). Bud6p interacts with actin
(2), which also participates in diploid bud site selection
and cellular morphogenesis (18, 60, 88, 91). Thus, Spa2p,
Pea2p, and Bud6p represent an important group of proteins that
participate in many common cellular processes; perhaps these proteins
help regulate the actin cytoskeleton during polarized cell growth. The
similar localization patterns of Spa2p, Pea2p, and Bud6p together with
the common phenotypes of cells that lack these proteins suggest that
these components may function very closely, perhaps as a complex, in
the same processes. Direct evidence for such a complex has not been
described.
Like Spa2p, components of several mitogen-activated protein kinase (MAPK) pathways also participate in the process of polarized cell growth (35, 46). MAPK pathways are composed of a cascade of protein kinases which act sequentially to transmit signals upon perception of external stimuli or internal cues; these signals ultimately result in various cellular responses, such as cell growth or differentiation (52, 85). The MAPK cascade includes a MAPK; a MAPK kinase (MEK), which phosphorylates and activates MAPK; and a MEK kinase (MEKK), which phosphorylates and activates MEK. In the budding yeast, at least two MAPK pathways participate in cell growth and differentiation. The mating response requires the Fus3p-Kss1p pathway (59, 95), which functions downstream of the Ste20p kinase (43). This pathway is composed of two MAPKs, Fus3p and Kss1p (21, 22, 29); the MEK Ste7p (25); and the MEKK Ste11p (83). Ste11p, Ste7p, and Kss1p also function in pseudohypha formation (48, 51, 69). The other MAPK pathway, the Slt2p (Mpk1p) MAPK pathway, functions downstream of the yeast protein kinase C homolog, Pkc1p, to maintain cellular integrity during polarized growth (46). Components of this pathway include the MAPK Slt2p (Mpk1p) (53, 84); two homologous and redundant MEKs, Mkk1p and Mkk2p (37); and the MEKK Bck1p (Slk1p) (15, 44). Defects in this pathway lead to cell lysis at elevated temperatures and failure to form proper mating projections (15, 24, 45). This pathway is also activated in response to mating pheromone and at the G1-S transition when bud emergence is initiated, consistent with its role in cell polarity (24, 94). The concomitant involvement of both Spa2p and components of these MAPK pathways in mating, pseudohypha formation, and bud growth raises the possibility that Spa2p and perhaps other polarity proteins might interact with signaling components. Genetic interactions between SPA2 and BCK1 (SLK1) and between SPA2 and SLT2 (MPK1) have been demonstrated (15, 16). Other interactions have not been uncovered.
In this study, we analyzed different SPA2 deletions and investigated the interactions among a number of the different polarity proteins and signaling components. We provide evidence that Spa2p is a complex protein with many important domains. Spa2p physically interacts with Pea2p and Bud6p, and these proteins cosediment at approximate 12S, suggesting that they form a multiprotein complex. Spa2p interacts with Pea2p via the conserved SHD-II, which is important for both the stability and localization of Spa2p and Pea2p. In addition, Spa2p and Bud6p interact with components of MAPK pathways. The N-terminal 150-amino-acid MEK-interacting region of Spa2p contains a conserved domain, SHD-I, that is important for mating and other Spa2p functions. The signaling activities of two MAPK pathways are altered in spa2 mutants. Taken together, these results suggest that Spa2p, Pea2p, and Bud6p are part of a large multiprotein complex that may exert its function through regulation of the actin cytoskeleton; this complex may link polarity components and signaling pathways during polarized cell growth.
MATERIALS AND METHODS
|
|
|---|
Strains, media, and microbiological techniques. The yeast strains used in this study are listed in Table 1. Growth media and genetic manipulation of yeast strains were as described by Sherman et al. (77). Yeast transformations were performed by the lithium acetate procedure (38) or the one-step method (13).
|
Construction of yeast strains. Y2003 (PEA2::HA) and Y2004 (PEA2::myc) were constructed by epitope tagging the PEA2 gene in a haploid wild-type yeast strain, Y762, by the strategy described by Schneider et al. (76). Primers 5'-GAG GCA AAC ACC TCG CTG GCG CTT AAT AGA GAC GAT CCA CCA GAT ATG CTA AGG GAA CAA AAG CTG GAG-3' and 5'-ATT CTT CTT ATT CTA TAT TTA TAT ATC AAT GTT TTA TAA TAA GAT GTT TAT TCA CTA TAG GGC GAA TTG-3' were used to amplify a region of pMPY-3XHA (for the hemagglutinin [HA] tag) or pMPY-3XMYC (for the c-myc tag). The resulting PCR product of approximately 1.5 kb contains a URA3 gene flanked by direct repeats encoding three copies of the HA or c-myc epitope (76). Both ends of the PCR fragment contain about 50 bp of PEA2 sequences surrounding the site of fragment insertion. Each DNA fragment was used to transform Y762. Transformants that had integrated the fragment correctly at the chromosomal locus were identified by PCR analysis. The integrants were allowed to grow overnight in YPAD (77) and plated onto 5-fluoro-orotic acid plates. 5-Fluoro-orotic acid-resistant colonies were checked by PCR for loss of the URA3 gene through homologous recombination between the two repeated epitope-coding sequences; this leaves a single in-frame epitope-coding sequence at the site of integration. Proper formation of the epitope-tagged proteins was further confirmed by immunoblot analysis. The tagged genes contain approximately 40 additional codons for the epitope plus linker sequences, and the resulting protein is approximately 5 kDa larger than the wild-type proteins.
The doubly tagged strain Y2009 was constructed by tagging the 3' coding sequence of BUD6 with HA in strain Y2004 by the procedure described above. The tag is inserted before the last 10 codons of Bud6p. The primer pair used was 5'-GAA AAT TTT GTG GGT AAT TCA AAC CTG AAA AAA TCG GGA GGC TTG AAG AAG AGG GAA CAA AAG CTG GAG-3' and 5'-CAA AAT ATG CTC TCA AAT TTG CTT CAT CCT TCT GCT TTC TTA TCC TTT CTA TCA CTA TAG GGC GAA TTG-3'. All of the tagged strains used in this study (Y2003, Y2004, and Y2009) appear normal in growth and form mating projections similar to those of wild-type cells after pheromone treatment. Y1213 was generated by deletion of STE5 from Y864 by a method previously described (5). Primers 5'-CTA AAA AAG GAA GAT ACA GGA TAC AGC GGA AAC AAC TTT TAA ATG ATG GAA CTG AGA GTG CAC CAT AAA-3' and 5'-C GGG ATG CTT TCT TTT TAT TAT TGC ATA AAA TTT AGT GTA TAC TCT ATA TTG AGC TGA TTT AAC AAA AAT-3' were used to amplify TRP1 from plasmid pRS314 (78). The resulting PCR product contained a TRP1 gene flanked by 50 bp of sequences upstream and downstream of STE5 coding region. This fragment was transformed into Y864. Correct substitution at the STE5 locus was verified by PCR. The resulting strain (Y1213) does not form mating projections after
-factor treatment.
Y2002 was constructed by deletion of PEA2 from yeast strain
Y762 as described above with primers 5'-C GAA GTC CTG TGT TCG AGA GGG
AGA ATA ACG GTG GAT ATC ACG TTT CAT AAG CGC GCC TCG TTC AGA ATG-3' and
5'-C TTC TTA TTC TAT ATT TAT ATA TCA ATG TTT TAT AAT AAG ATG TTT ATT
CAC TCT TGG CCT CCT CTA GTA-3' to amplify HIS3 from pRS313
(78). Correct substitution of PEA2 was verified by PCR analysis. This strain (Y2002) forms peanut-shaped mating projections upon exposure to mating pheromone as described for typical
pea2 mutants (86).
The spa2(1-2, 116-1466) alleles in Y2011 and
Y2016 were generated from Y762 and Y2014 (a segregant of 105A-1
[23]), respectively, as described by Schneider et al.
(76). The primers used were 5'-CG AGC CAC CGA AAC AGA ATA
AAC AAA AGA AAA GAA AGA GTA AAC ATG GGT AGG GAA CAA AAG CTG GAG CTC-3'
and 5'-GG GGG CCG TGG AGC ATC CAA ATC CTT GTC GAA CCC TCT TCT CTT GAT
CTC TAG GGC GAA TTG GGT ACC GGG-3'. The resulting spa2
allele has three in-frame copies of HA-coding sequence replacing codons
3 to 115 of SPA2.
HA::SPA2 deletion constructs and phenotypic assays. A fragment containing SPA2 with a NotI site after the first codon (created by K. Madden) was cloned into pRS315, and a NotI fragment encoding three copies of an HA epitope was introduced into the NotI site, creating plasmid pBU4. The ApaI site in pBU4 was destroyed by filling in with T4 DNA polymerase, and a linker with the ApaI site and stop codons in all three frames was inserted into the HindIII-XhoI sites of this plasmid, resulting in pBU19. A series of 3' deletions were made from pBU19 by using the Double-Stranded Nested Deletion Kit from Pharmacia, Piscataway, N.J. pHA::spa2(1-481, 1208-1466) was created by excising the internal SphI fragment of SPA2. pHA::spa2(1-13, 265-1466) and pHA::spa2(1-13, 265-552) were created by digesting pHA::SPA2(1-1466) and pHA::spa2(1-552), respectively, with EcoRV and ligating the in-frame sites. The last codon of each deletion was determined by DNA sequence analysis (W. M. Keck Foundation Biotechnology Resource Laboratory, Yale University). (The plasmid constructs generated are listed in Table 3 and diagrammed in Fig. 3.)
Plasmids were transformed into spa2
strains for
phenotypic analyses. Protein levels in lysates prepared from the
resulting strains were examined by immunoblot analysis with anti-HA
monoclonal antibodies (MAb) (see below). Immunolocalization of the
proteins is described below.
Complementation of the different defects was determined as follows.
Complementation of defects in projection formation was carried out with
yeast strains Y2007 and Y2008. Cells carrying the HA::Spa2p
deletion construct were treated with
-factor mating pheromone (Sigma
Chemical Co., St. Louis, Mo.) for 1.5 h as described previously
(50), fixed, and observed under a light microscope. Complementation of the bud site selection defect was assessed with
strain Y2001. Budding patterns were analyzed by Calcofluor staining
(50). Complementation of the pseudohyphal defect was assayed
in Y1209 (
background) as described by Roemer et al. (71). Complementation of spa2
colethality with
cdc10-10, swi4-100, bem2-101, or
slk1-1 was examined with yeast strains Y831, Y877, Y875, and
Y754, respectively, by using a colony sectoring assay (15).
Two-hybrid interactions. The plasmids used in the two-hybrid assay are listed in Table 2. Unless noted otherwise, the plasmids were constructed by amplifying the protein-coding sequences by PCR and inserting each fragment into the BamHI sites of vectors pSH2-1 (27, 32) and pACTII (22a). Typically the BamHI sites were created on both ends of the PCR fragment; for fragments containing endogenous BamHI sites, BglII sites were created and used instead. The orientations of the insert and fusion junctions were checked by restriction mapping and DNA sequence analysis (W. M. Keck Foundation Biotechnology Resource Laboratory, Yale University).
|
-D-galactopyranoside) plates
(89). The X-Gal plates with the filters were incubated at
30°C for up to 24 h. Blue color appeared within 2 h for the very strong interactions. The strength of the interactions was determined visually by the intensity of coloration.
For quantitative
-galactosidase (
-Gal) assays most experiments
were performed with strains grown in liquid medium as described by
Erdman et al. (23). However, for some of the two-hybrid
strains, the
-Gal activity was lost after continuous propagation in
liquid medium, presumably because the constructs are deleterious for cell growth. To circumvent this problem, yeast transformants were patched on plates containing selective medium. After incubation at room
temperature for 1 day, cells were scraped from the plate and
transferred to Z buffer for analysis (23).
-Gal activity was normalized to protein concentration in all cases. Three samples were usually analyzed for each interaction.
Antibodies. MAb against HA (clone 16B12) and c-myc (clone 9E10) were purchased from BAbCO, Richmond, Calif. A MAb against actin (clone C4) was purchased from ICN Biochemicals, Inc., Aurora, Ohio. Anti-Swi6p antiserum was obtained from Brenda Andrews' laboratory and affinity purified in a study by Madden et al. (49). Affinity-purified anti-Spa2p antiserum was as described by Snyder (80). Alkaline phosphatase-conjugated goat anti-mouse immunoglobulin G (IgG) and anti-rabbit IgG and CY3-conjugated goat antimouse antibodies were purchased from Jackson ImmunoResearch Laboratory, Inc., West Grove, Pa. Antibodies used in indirect immunofluorescence were preabsorbed with whole cells and spheroplasts of untagged wild-type yeast cells to remove nonspecific antibodies (10).
IP and immunoblot analyses. Overnight cultures grown in YPAD or selective media were diluted to an optical density at 600 nm (OD600) of 0.1 to 0.15 in fresh YPAD and grown to early log phase (OD600 = 0.3 to 0.5). Cells were then collected, washed, and lysed with glass beads in lysis buffer as described by Kamada et al. (40). Lysates were centrifuged for 10 min at 14,000 × g to remove cell debris. The clear lysates were subjected to immunoprecipitation (IP), or 1/3 volume of 4× Laemmli sample buffer (73) was added for immunoblot analysis.
IPs were performed by using the buffer system described by Kamada et al. (40). For each IP, 100 µg of total yeast protein in 450 µl of IP buffer was incubated with antibodies for 1.5 h at 4°C. For IP with MAb 16B12 or 9E10, a 1:150 dilution of crude ascites fluid was used. For IP with affinity-purified anti-Spa2p or preimmune serum, a 1:100 dilution of the affinity-purified antibody was used. To collect the immunocomplex, 50 µl of a 1:2 IP buffer suspension of protein A-conjugated Sepharose beads (Pierce, Rockford, Ill.) was added, and the mixture was incubated for an additional 1.5 h at 4°C with constant mixing. The beads were pelleted and washed four times with IP wash buffer and then eluted with 50 µl of lysis buffer plus 25 µl of 4× Laemmli sample buffer. For immunoblot analysis, cell lysates or immunoprecipitates in Laemmli sample buffer were fractionated by sodium dodecyl sulfate-8% polyacrylamide gel electrophoresis (SDS-8% PAGE), blotted onto Immobilon (Millipore, Bedford, Mass.), and probed with primary antibody. The reactive bands were visualized with alkaline phosphatase-conjugated antibodies and CDP-Star (Boehringer Mannheim Corp., Indianapolis, Ind.) detection reagent or the NBT-BCIP (nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate) color detection system as described by Harlow and Lane (34).In vitro kinase assays.
Slt2p kinase activity was assayed as
described by Kamada et al. (40). Cells containing
pFL44-SLT2HA (94) were grown to early log phase
(OD600 = 0.2 to 0.3), collected, and lysed with glass
beads. For each kinase reaction, 250 µg of total yeast proteins was
preincubated with protein A-conjugated Sepharose beads for 1 h,
and the supernatant was immunoprecipitated with MAb 16B12. IP mixtures
were then incubated with 0.25 mg of myelin basic proteins (MBP) per ml
and 15 µCi of [
-32P]ATP at 30°C for 25 min. The
reaction were stopped by addition of sample buffer. The phosphorylation
of MBP was analyzed by SDS-15% PAGE followed by autoradiography.
Kinase activities were quantified by using Bio-Rad Multi Analyst,
version 1.0.2. As a control, background phosphorylation of MBP was
determined in a parallel assay with strains lacking HA-tagged Slt2p.
Indirect immunofluorescence microscopy.
Indirect
immunofluorescence of yeast cells containing HA::Spa2p
deletions and Pea2p::myc was performed as described
previously (30). Y2007 yeast strains with plasmids were
grown overnight in selective media, diluted to an OD600 of
0.1 in fresh YPAD, and grown to early log phase (OD600 = 0.3).
-Factor was added to a final concentration of 5 µg/ml as
described by Madden and Snyder (50). Cells were fixed in
3.7% formaldehyde for 60 min and spheroplasted. Spheroplasts were
allowed to settle on poly-L-lysine-coated slides and
incubated with preabsorbed primary antibodies (MAb 16B12 for the HA
epitope tag or MAb 9E10 for the c-myc epitope tag) overnight at 4°C.
For detection of primary antibodies, preabsorbed CY3-conjugated goat
anti-mouse IgG was used.
Sucrose gradient velocity sedimentation. Cell lysates were prepared from strain Y2009 and subjected to velocity centrifugation. Cells were grown to early log phase (OD600 = 0.3 to 0.5) in YPAD and lysed by vortexing in modified phosphate-buffered saline buffer (0.17 M NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.2) containing glass beads and protease inhibitors. The crude extract was centrifuged at 16,000 × g at 4°C for 10 min. Prior to loading onto the gradient, 160 µl of crude extract was centrifuged at 110,000 × g at 4°C for 5 min in an A-100/18 Airfuge rotor (Beckman, Instruments., Fullerton, Calif.). Molecular size standards (40 µl of a mixture of thyroglobulin [19.4S], catalase [11.3S], aldolase [7.4S], and bovine serum albumin [4.4S] at 10 mg/ml in the same buffer) were mixed with the supernatant and then loaded onto a 5-ml linear sucrose gradient (5 to 20%, wt/vol) in modified phosphate-buffered saline buffer containing protease inhibitors. Gradients were centrifuged at 40,000 × g at 4°C for 20 h in an SW55Ti rotor (Beckman). Approximately 175-µl aliquots were withdrawn from the bottom of each tube by using a peristaltic pump and analyzed by immunoblot analysis as described above. Proteins on the immunoblots were quantified by using the National Institutes of Health Image version 1.59. Molecular size standards were resolved on 8% polyacrylamide gels stained with Coomassie blue. To test whether the migration of the 12S complex is affected by detergent, 0.1% Triton X-100 was added to the protein lysate prior to centrifugation. Analysis of the 12S complex in pheromone-treated cells was carried out by incubating yeast cells grown to an OD600 of 0.3 with 5 µg of mating pheromone per ml for 2 h. Cell lysates were prepared and analyzed as described above.
RESULTS
|
|
|---|
Spa2p and Pea2p form a stable complex in vivo.
spa2
and pea2
cells share many phenotypes, and Spa2p and Pea2p
localize to the same regions of the cell (30, 80, 86). To
determine whether Spa2p and Pea2p interact physically, co-IP experiments and two-hybrid analysis were performed. For the co-IP experiments, we tagged the chromosomal PEA2 gene immediately
upstream of the translational stop codon with a DNA fragment encoding
three copies of either an HA epitope or a c-myc epitope, using the
method described by Schneider et al. (76). Yeast cells
expressing the epitope-tagged PEA2 gene
(PEA2::HA or
PEA2::myc) form mating projections that
are indistinguishable from those of isogenic wild-type cells, and the
Pea2p::HA and Pea2p::myc proteins localize to
polarized growth sites in a manner identical to that described for
wild-type Pea2p (86) (see Fig. 4, bottom panel a, which
shows the localization of Pea2p::myc). Thus, the
epitope-tagged proteins are functional. Immunoblot analysis indicates
that the epitope-tagged Pea2 proteins migrate as a doublet at
approximately 60 kDa (see Fig. 1A for Pea2p::HA and Fig. 5
for Pea2p::myc), consistent with the predicted molecular
mass. This protein is not observed in control strains (see Fig. 1A,
lanes 3, 4, and 6).
strain (Fig. 1A,
rightmost lane). Reciprocally, the anti-HA or anti-c-myc MAb can
specifically precipitate Spa2p from
PEA2::HA and
PEA2::myc lysates, respectively, but
not from extracts of untagged control strains (Fig. 1B). Thus, Spa2p
and Pea2p are tightly associated with each other in a complex in vivo.
|
-Gal activity in a LexA-responsive
lacZ reporter yeast strain (see Table 4). The interactions
between Spa2p and Pea2p fusion proteins are specific, since these
fusions do not activate transcription either on their own, when
coexpressed with other fusions, or in the presence of vectors alone
(Fig. 2A and data not shown). We could
not test whether LexA::Pea2p interacts with
AD::Spa2p because the LexA::Pea2p construct
activates transcription in the absence of AD plasmids. Nevertheless,
the co-IP and two-hybrid results both demonstrate that Spa2p interacts
with Pea2p.
|
Spa2p interacts with Pea2p through SHD-II, which contains
coiled-coil sequence.
To delineate the region of Spa2p that
interacts with Pea2p, we constructed LexA fusions containing various
fragments of SPA2 coding sequence and used the two-hybrid
system to test for interaction with AD::Pea2p (Fig. 2B and
C). LexA::Spa2p(1-698), when coexpressed with
AD::Pea2p, resulted in an increase of
-Gal activity,
indicating a Pea2p-interacting region in the first 698 residues of
Spa2p. This interaction was not observed with
LexA::Spa2p(512-1118) or LexA::Spa2p(743-1466).
-Gal (Fig. 2B and C). Thus, the C-terminal boundary for Pea2p
interaction resides between residues 488 and 530. Because
LexA::Spa2p(375-698) interacts with AD::Pea2p, the
N-terminal boundary likely lies after residue 375 (Fig. 2C). The region
from residue 375 to 530 could not be directly tested for interaction in
this assay because a LexA fusion containing only this region activates
transcription in the absence of an AD construct. These results indicate
that the region necessary for Pea2p interaction lies between residues 375 and 530. This region is predicted to have mostly a coiled-coil structure and includes SHD-II.
It is possible that the interaction between Spa2p and Pea2p is through
nonspecific interactions between coiled-coil sequences. This does not
appear be the case, because neither Spa2p nor Pea2p interacts with the
coiled-coil proteins Cik1p and Kar3p in parallel two-hybrid tests
(54, 63) (Fig. 2A and data not shown); furthermore, Spa2p
failed to interact with two other coiled-coil proteins, Nuf1p and NuMA
(42, 55, 81a, 90), and Spa2p failed to interact with itself
in similar assays (data not shown). Thus, Spa2p specifically interacts
with Pea2p through a region predicted to contain coiled-coil sequence.
Deletion analysis reveals multiple regions involved in proper
localization of Spa2p.
Spa2p is a large protein, and
spa2
phenotypes suggest that it is involved in many
aspects of polarized cell growth (30, 80). To determine
which region of Spa2p is important for its localization and whether
there are separable functional domains in the protein, we generated and
analyzed a series of SPA2 deletion mutants. To facilitate
detection of Spa2p, a DNA segment encoding three copies of HA was fused
immediately before the SPA2 coding sequence corresponding to
the N terminus. Full-length HA::Spa2p(1-1466) localizes
in a pattern indistinguishable from that of wild-type Spa2p and is
fully functional because it complements all spa2
defects,
including projection formation, bud site selection, pseudohyphal growth, and spa2
colethality, with cdc10-10,
swi4-100, bem2-101, and slk1-1 (Table
3). A series of deletion constructs were
prepared from the pHA::SPA2(1-1466) construct
(Fig. 3A and Table 3). The levels of
HA::Spa2p produced from these constructs were examined by
immunoblot analysis (Fig. 3B). Constructs lacking either part or all of
the coiled-coil domain and the Pea2p-interacting SHD-II failed to
produce detectable amounts of HA::Spa2p [e.g.,
pHA::spa2(1-430), -(1-193), -(1-99,
537-552), and -(1-99, 537-1466)]. In contrast, pHA::spa2(1-13, 266-552), which contains almost
exclusively the entire coiled-coil domain and SHD-II, produces protein
at a level comparable to that for the full length construct (Fig. 3B).
These observations suggest that an intact coiled-coil domain and SHD-II are important for the stability of Spa2p.
|
|
|
Proper localization of Spa2p is required for the localization of
Pea2p to growth sites.
It was reported previously that in
spa2
cells, Pea2p was not detectable by immunoblot
analysis with anti-Pea2p antiserum (86). Thus, it was not
possible to determine whether Spa2p only affected the stability of
Pea2p or whether Spa2p was directly involved in Pea2p localization.
However, Pea2p::HA and Pea2p::myc are readily
detected by immunoblot analysis when SPA2 is deleted, albeit
at a lower level (Fig. 1A, second lane) (data not shown for
Pea2p::myc). This allows analysis of Pea2p localization in the absence of Spa2p or in the presence of Spa2p deletion constructs.
strains
carrying the pHA::spa2 deletion constructs
described above was analyzed (Fig. 4, bottom panels). All strains that
localize HA::Spa2p properly also localize
Pea2p::myc. For example, a deletion construct with most of
the carboxy terminus of Spa2p removed [Spa2p(1-736)] still localizes
Pea2p::myc to the growth sites (Fig. 4, bottom panel b).
These results indicate that full-length Spa2p is not required for
Pea2p::myc localization. Moreover, constructs that exhibit weak Spa2p localization [e.g., Spa2p(1-530)] at growth sites also exhibit very weak Pea2p::myc staining, suggesting a
correlation between the efficiency of Spa2p localization and that of
Pea2p::myc. Finally, all deletion constructs tested with
either part of the Pea2p-interacting region removed [e.g.,
HA::Spa2p(1-481, 1208-1466)] or the localization of Spa2p
disrupted [e.g., HA::Spa2p(1-13, 265-552)] also fail to
localize Pea2p::myc. These results indicate Pea2p
localization at growth sites is dependent upon both its interaction
with Spa2p and the Spa2p localization sequences.
Full-length Spa2p is required for all aspects of Spa2p
function.
The indirect immunofluorescence analysis showed that
only a portion of Spa2p is required for localization of itself and
Pea2p. We also analyzed the abilities of the truncated Spa2 proteins to
complement various defects of the spa2
mutant. The
results of these studies are summarized in Table 3 and Fig. 3. Only the full-length Spa2 protein is capable of rescuing the different defects
of spa2 mutants, including the bud site selection defect, projection formation defect, pseudohypha formation defect, and colethality with bem2-101, cdc10-10,
slk1-1, and swi4-100. These results suggest that
full-length Spa2p is required for multiple aspects of its biological
functions. Alternatively, because the larger HA::Spa2p
derivatives are present at lower levels (Fig. 3B), the level of Spa2p
may be important for its function.
Spa2p interacts with Bud6p (Aip3p). We also tested whether Spa2p interacts with other polarity components by using the two-hybrid system. LexA::Spa2p(1-1466) was tested for interaction with AD fusions of Bud6p (Aip3p), Bem1p, Cdc24p, Cdc42p, Chs5p, or Act1p (actin) (see references 2, 7, 39, 61, 65, 74, and 79 for publications describing these proteins). No reproducible interaction was observed with Bem1p, Cdc24p, Cdc42p, Chs5p, or Act1p. However, interaction was observed with the AD::Bud6p(275-788) and AD::Bud6p(358-768) constructs. A low level of interaction was observed with a shorter Bud6p construct, AD::Bud6p(478-788) (Table 4). These results suggest that the region of Bud6p from residue 275 to 478 contributes to its interaction with Spa2p. Attempts to coimmunoprecipitate Spa2p and Bud6p epitope tagged with HA or c-myc at either its N terminus or C terminus were not successful. However, as demonstrated below, a significant portion of Bud6p cosediments in a similar-size complex with Spa2p, raising the possibility that these two proteins associate in vivo.
|
Sedimentation of Spa2p, Pea2p, and Bud6p. The interactions described above suggest that Spa2p, Pea2p, and Bud6p may be part of a large multiprotein complex. To test this possibility, velocity sedimentation experiments were performed. For detection of all three proteins, we constructed an SPA2 BUD6::HA PEA2::myc strain. This strain has a normal growth rate and forms pointed mating projections similar to those of wild-type cells after pheromone treatment. Cell lysates were prepared from this strain, and cell debris was removed. The resulting lysates containing the soluble material were separated in a 5 to 20% sucrose gradient. Fractions from the gradient were collected and probed with anti-Spa2p antiserum, an anti-HA MAb (to detect Bud6p::HA), an anti-c-myc MAb (to detect Pea2p::myc), and an antiactin MAb. As shown in Fig. 5, most of the Spa2p, Pea2p::myc, and Bud6p::HA cosediment and peak at approximately 12S. A small amount of Pea2p migrates slightly slower than Spa2p; this is likely due to cosedimentation with Spa2p degradation products. Most of Bud6p cosediments with Spa2p, although a small portion sediments at a higher S value (e.g., see fraction 18). Actin present in these lysates remains at the top of the gradient. Similar results for Spa2p and HA::Bud6p were observed when cell lysates from an HA::BUD6 strain (containing Bud6p tagged at the N terminus) were analyzed. Control experiments analyzing another complex, the Cik1p-Kar3p microtubule motor complex (62), have shown that this motor complex sediments much more slowly than Spa2p, indicating that the 12S complex is relatively specific for these proteins.
|
Spa2p interacts with components of two MAPK pathways involved in
polarized morphogenesis.
Two MAPK signaling pathways, the Fus3p
Kss1p mating pathway and the Slt2p cell integrity pathway, have been
implicated in yeast polarized cell growth (35, 46). We
tested whether Spa2p interacts with components of these two pathways by
using the two-hybrid system. As shown in Table
5 and Fig.
6A, LexA::Spa2p(1-1466) interacts with AD fusions of Mkk1p and Mkk2p, the MEKs of the Slt2p
pathway, and Ste7p and Ste11p, the respective MEK and MEKK needed for
the mating response and pseudohypha formation. The scaffolding protein
Ste5p (14a, 67a) is not required for the interaction between
Spa2p and Ste11p or Ste7p, since these interactions still occur in a
ste5
strain (Table 5). Spa2p does not interact in this
assay with other signaling components, including Pkc1p, Ste20p, Slk1p,
Slt2p, and Pbs2p (Pbs2p is the MEK of the Hog1p pathway, which mediates
responses to high external osmolarity [8]) (Table 5,
Fig. 6A, and data not shown). Attempts to coimmunoprecipitate Spa2p and
its interacting kinases produced either at wild-type levels (Ste7p,
Mkk1p, and Mkk2p), at high copy (Mkk1p), in either the presence or
absence of mating pheromone, or from a GAL1 promoter (Ste11p) were not successful. This suggests that these interactions may
be either weak or transient in vivo or that they require different physiological conditions.
|
|
The MEK-interacting domain of Spa2p resides in the conserved N-terminal region. To determine the MEK-interacting region of Spa2p, we tested for interactions between LexA fusions of different Spa2p domains and the AD fusions of Mkk1p, Mkk2p, and Ste7p. As shown in Figure 6C, LexA::Spa2p(1-698), which contains the Pea2p-interacting region, also interacted with all three MEKs. However, the fusion LexA::Spa2p(1-488), which did not interact with AD::Pea2p, still interacts with AD fusions of all three MEKs; another fusion, LexA::Spa2p(112-530), which is positive for Pea2p interaction, failed to interact with any of these three MEKs. A shorter fusion, LexA::Spa2p(1-150), containing only the first 150 residues of Spa2p interacts strongly with each of the AD::MEKs, although this construct activates transcription slightly on its own (Fig. 6B). There was no such increase with LexA::Spa2p(1-150) when the vector control plasmid was tested (Fig. 6B). In addition, AD::Spa2p(1-150), which does not activate transcription alone, also interacts with LexA::Ste7p (data not shown). Thus, the MEK-interacting region of Spa2p lies within the first 150 residues (Fig. 6B). This region contains a highly conserved sequence (SHD-I) with two repeats that are shared with Sph1p, a Spa2p homolog, and several unknown proteins in other organisms (71).
To determine if the MEK-interacting region is important for Spa2p function, we substituted codons 3 to 115 with a sequence containing three copies of the HA-coding region by using the PCR method (76). The resulting strain produces a protein, Spa2p(1-2, 116-1466)::HA, that is expressed at levels indistinguishable from those produced by wild-type cells (data not shown). In mating assays, strains containing this protein are defective in mating, similar to spa2
cells (Table
6). These cells also display defects in
bud site selection and mating projection formation similar to those of
spa2
cells (data not shown). Thus, the conserved region
of the MEK-interacting domain of Spa2p is important for its function.
|
The N-terminal nonkinase domains of Ste7p and Mkk1p interact with Spa2p. Ste7p and Mkk1p each contain a kinase domain at their C termini and putative regulatory domain at their N termini (37, 82). To determine the Spa2p-interacting region of each of these kinases, AD fusions containing N-terminal and C-terminal regions of both Mkk1p and Ste7p were constructed and tested for interactions with LexA::Spa2p. AD::Ste7p(172-515), which contains the kinase domain, did not interact with LexA::Spa2p, whereas AD::Ste7p(1-172) and AD::Ste7p(1-136), which contain the nonkinase regions of Ste7p, both interacted strongly with Spa2p (Fig. 7B). Thus, Spa2p interacts with the amino-terminal nonkinase region of Ste7p.
|
Effects of Spa2p on the MAPK signaling pathways.
The
interaction of Spa2p with Mkk1p and with Mkk2p raises the possibility
that Spa2p might affect the signaling activity of the Slt2p MAPK. To
test this possibility, we determined the relative Slt2p kinase
activities in wild-type and spa2 mutant strains. An HA
epitope-tagged Slt2p was immunoprecipitated from SPA2,
spa2
, and spa2(1-2, 116-1466) cells
(the latter lack the MEK-interacting domain) and incubated with
[
-32P]ATP and MBP, a MAPK substrate. As shown in Fig.
8, Slt2p proteins immunoprecipitated from
the spa2 mutant strains exhibit a two- to threefold increase
in in vitro phosphorylation of MBP relative to that for wild-type
control strains. These results demonstrate that the activity of the
Slt2p MAPK pathway is elevated in the spa2 mutants.
|
cells. As shown in Fig. 9, the
slow-mobility isoform of Swi6p, which is the phosphorylated form of the
protein (49), is more intense in the protein extract prepared from a spa2
strain than in that from wild-type
cells. Quantification indicates that the level of Swi6p
hyperphosphorylation is about 25% in wild-type cells and 50% in
spa2
cells (Fig. 9). The same phenomenon was observed
when the phosphorylation patterns of Swi6p in diploid wild-type and
spa2
/spa2
mutant cells were compared (data not shown).
These results suggest that deletion of SPA2 results in a
higher activity of the Slt2p pathway which causes
hyperphosphorylation of Swi6p. Hyperphosphorylation of Swi6p was
also observed in pea2
cells (Fig. 9). This is
consistent with the observation that Spa2p and Pea2p function as
a complex in the same process.
|
and wild-type strains after treatment with different concentrations of mating pheromone. spa2
fus2::lacZ strains either treated with low
levels of mating pheromone (0.6 nM) or not treated with pheromone
reproducibly exhibit a reduced level of expression (approximately two-
to threefold) relative to that of wild-type cells (Table
7). Treatment of cells with high levels
of mating pheromone or analysis of
fig1::lacZ strains revealed little or no reproducible difference between spa2
and wild-type
cells (Table 7 and data not shown). spa2(1-2,
116-1466) cells, which lack SHD-I, also exhibit reduced
fus2::lacZ expression in the presence of a low concentration of or no mating pheromone, similar to that of a
spa2
mutant (Table 7). These experiments indicate that SHD-I is important for optimal MAPK signaling.
|
Bud6p interacts with Ste11p. We also used the two-hybrid system to test for interactions between Pea2p, Bud6p, and components of the signaling pathways described above. AD::Pea2p did not interact with LexA::Ste11p, LexA::Ste7p, or LexA::Fus3p (not shown). We could not test for Pea2p interaction with Mkk1p, since LexA::Mkk1p, like LexA::Pea2p, activates reporter transcription by itself. However, AD::Bud6p(358-768) and AD::Bud6p(275-788) showed strong transcription activation when coexpressed with LexA::Ste11p (Table 8), suggesting an interaction between Bud6p and Ste11p. The level of interaction between AD::Bud6p(478-788) and LexA::Ste11p was similar to the background level. These interactions suggest that the region from residue 358 to 478 contributes to the Ste11p interaction. The Bud6p fusions did not interact, as determined by two-hybrid analysis, with other signaling components tested, including Ste7p, Fus3p, Mkk1p, Mkk2p, Slt2p, and Pbs2p. Co-IP between Myc::Bud6p and HA::Ste11p was not successful, suggesting that the interaction may be transient or weak in vivo.
|
DISCUSSION
|
|
|---|
In this study, we demonstrated that the 1,466-amino-acid protein Spa2p contains multiple domains that interact with the polarity proteins Pea2p and Bud6p. Together, these polarity proteins may constitute a large multiprotein complex that functions to promote polarized cell growth through regulation of the actin cytoskeleton (Fig. 10). We also showed that components of this putative multiprotein complex interact with constituents of two MAPK signaling pathways involved in budding, mating, and pseudohypha formation (Fig. 10). These different interactions may provide links by which polarity components and signaling pathways can coordinate the complex processes of polarized growth.
|
Spa2p contains multiple protein-interacting domains that are important for its function. Sequence analysis of Spa2p has revealed a variety of domains within this protein (30, 71). There are three large regions of over 100 amino acids (SHD-I, -II, and -V) that are homologous to Sph1p, a related protein in yeast. The second of these, SHD-II (amino acids 429 to 535), contains a large putative coiled-coil segment (71). In addition, Spa2p has two regions that are unique: a coiled-coil domain from residue 281 to 428 as well as a stretch of 9-amino-acid repeats between residues 816 and 1087 (30).
We have found that Spa2p interacts with Pea2p and that the Pea2p-interacting domain maps to a region between residues 375 and 530. This region is composed mostly of SHD-II, which is primarily coiled coil, and a small portion of the coiled-coil region that is unique to Spa2p. Pea2p also possesses a putative coiled-coil domain from residue 236 to 327 (86). The interaction of the Spa2p coiled-coil segments with Pea2p raises the possibility that the two polarity proteins might associate with each other via a coiled-coil interaction. Although much of the Pea2p-interacting region of Spa2p is homologous to Sph1p, Pea2p and Sph1p do not interact by using the two-hybrid system (71). Thus, it is likely either that the region outside the SHD-II region contributes to interaction with Spa2p or that the SHD-II regions of Spa2p and Sph1p interact with different proteins. The Pea2p-interacting region of Spa2p is important for stability, localization, and function of the protein. Deletions that remove most of this region result in loss of detectable Spa2p (Fig. 3 and Table 3), and immunolocalization analyses indicate that this region in conjunction with one of two other regions of Spa2p is required for localization to growth sites within the cell (Fig. 4). Arkowitz and Lowe (3) have also mapped a localization domain of Spa2p to this same region (see below), and Valtz and Herskowitz have found that loss of Pea2p results in mislocalization of Spa2p (86). Thus, interaction of this region with Pea2p is critical for Spa2p localization and function. We have also found a region within the N-terminal 150 amino acids of Spa2p that interacts with the yeast MEKs Ste7p, Mkk1p, and Mkk2p (Fig. 6) and an as-yet-unidentified region that interacts with Ste11p. All of these kinases belong to signaling pathways that have been implicated in polarized morphogenesis and mating (25, 37, 48, 69, 83, 94). The MEK-interacting region of Spa2p overlaps with SHD-I, which is homologous to domains in Sph1p and proteins in other organisms, such as humans and nematodes (71). In addition, Roemer et al. have found that Sph1p also interacts with these same MEKs (71). SHD-I contains two conserved repeated sequences called SDRs (for Spa2 direct repeat). We speculate that the conserved SDRs interact with MEKs in a wide variety of organisms. Several other domains exist in the Spa2p protein. SHD-V and at least two other smaller SHDs are predicted from the Spa2p sequence, in addition to the Spa2p unique coiled-coil domain segment and 9-amino-acid repeats. We have found that Bud6p and Ste11p interact with Spa2p as determined by the two-hybrid system, and Roemer et al. found that Sph1p also interacts with these two proteins (71). Thus, it is likely that other SHDs (III, IV, and/or V) bind to Bud6p and Ste11p. Presumably other proteins also bind Spa2p domains. One additional candidate is Bni1p; bni1
mutants have
phenotypes similar to those of spa2
cells, and Bni1p
localizes to growth sites similarly to Spa2p (26).
Additional localization and functional domains of Spa2p. In addition to the Pea2p-interacting domain, our analysis of HA::Spa2p deletions also revealed two other, less defined regions that are important for proper Spa2p localization at growth sites. One contains the sequence located between residues 14 and 264, and the other resides between residues 552 and 1466. Either region, when combined with the Pea2p-interacting SHD-II, is sufficient for targeting Spa2p to growth sites (Table 3; Fig. 3 and 4). It is likely that these two regions either contain additional sequences that facilitate Spa2p targeting or help Spa2p adopt a conformation that is competent for localization to growth sites. The different sequences that help localize Spa2p also are critical for localization of Pea2p (Table 3 and Fig. 4).
As this paper was being prepared, Arkowitz and Lowe reported that a region of Spa2p from amino acids 397 to 549 is sufficient for targeting a Spa2-green fluorescent protein (GFP) fusion to growth sites (3). Although this region overlaps well with the Pea2p-interacting region/localization domain that we identified, they did not identify the other regions of the proteins that are important for Spa2p localization. The discrepancy between our results and theirs may be due to the difference in sensitivity of detection between GFP and indirect immunofluorescence microscopy or to differences in the stability of Spa2p-GFP and HA::Spa2p proteins. Regardless, our data indicate that other regions of Spa2p are important for its proper localization. Localization of Spa2p to the growth sites is not sufficient for its function. Only the full-length HA::Spa2p construct is capable of rescuing spa2 mutant defects (Table 3 and Fig. 3). Even the deletions removing fewer than 90 residues at the C terminus [i.e., HA::Spa2p(1-~1410) and HA::Spa2p(1-1380)] fail to complement the spa2 defects. Since this region overlaps with SHD-V, it is likely that SHD-V interacts with another component that functions in the same processes as does Spa2p. Alternatively, it is also possible that SHD-V contributes to the stability of the protein so that proteins lacking this region are present at lower levels [which is the case for HA::Spa2p(1-~1410) and HA::Spa2p(1-1380)] and are thus unable to provide proper Spa2p function. It is also important to note that although many Spa2p deletion constructs are capable of localizing to growth sites, their localization patterns are more diffuse over a broad region instead of forming a tight patch at growth sites as does the full-length protein. This is especially evident in pheromone-treated cells, in which the projection is wider in these mutants (Fig. 4); the wide projection might explain in part the broad distribution of the protein. Alternatively, as discussed further below, Spa2p is part of a multiprotein complex that functions early in the process of polarized cell growth. Thus, multiple regions of Spa2p are essential for the proper localization and function of Spa2p.Spa2p interacts with other polarity proteins to form a multiprotein
complex.
The results presented in this study indicate that Spa2p
interacts with at least two other polarity proteins, Pea2p and Bud6p, and that a large portion of these proteins cosediment in sucrose gradients as a 12S complex (Fig. 5), which we call the 12S polarisome. These data are consistent with the similar localization patterns of
these proteins and the similar phenotypes of spa2
,
pea2
, and bud6
cells (2, 14, 30, 81,
86, 93).
and bud6
mutant cells and the
tips of their mating projections are consistent with that expected for
a mutant with an altered cytoskeletal structure (reference
80 and data not shown). However, the 12S complex is
probably not always associated with actin, because actin does not
comigrate with it in a sucrose gradient and actin has a localization
pattern distinct from that of the 12S complex components. Furthermore,
the localization of Spa2p and Bud6p to growth sites does not require an
intact actin cytoskeleton (4, 81). Spa2p, Pea2p, Bud6p, and
actin each affect bud site selection in diploids and other polarized
growth processes, and all of these proteins localize to the incipient bud site, suggesting that they act very early in establishing and
maintaining polarity and may work together in some processes. The 12S
complex may function to regulate the actin cytoskeleton at an early
step in morphogenesis, perhaps directing the actin cytoskeleton to
specified growth sites in diploid cells and/or maintaining it in a more
concentrated region once polarized growth has been initiated. All
components of the proposed 12S complex, as well as the actin
cytoskeleton, are also important for projection formation during mating
(14, 30, 68, 86), which is a dynamic process that requires
tracking and responding to pheromone gradients. Thus, we hypothesize
that the 12S complex is particularly important for targeting,
maintaining, and/or remodeling the actin cytoskeleton during dynamic
growth periods.
Although our results indicate that Spa2p and Bud6p may function
together in the same complex to promote polarized cell growth, they are
likely to have different roles in this process, as suggested by three
lines of evidence. First, a subset of Bud6p does not cofractionate with
Spa2p and is likely affiliated with vesicles, indicating that these two
proteins are not always associated. Second, we found that GFP-Spa2p is
able to localize to growth sites in the bud6
cells (data
not shown). This result indicates that, unlike Pea2p, Bud6p is not
required for Spa2p localization (86). Third, although both
spa2
and bud6
cells are round and each form
less-polarized mating projections than wild-type cells, bud6
cells have less-severe polarity defects than those
of spa2
cells; the mating projections of
bud6
mutant cells are more pointed (and polarized) than
those of spa2
cells (data not shown). Moreover, the
phenotype of the spa2
bud6
double mutant is more
severe than that of single mutants. Cells with both genes deleted
appear to be larger and grow slower than cells with either gene
deleted(data not shown), and a higher proportion of spa2
bud6
cells than single mutant cells do not form mating
projections upon
-factor treatment (data not shown). The additive
morphological defects of the double mutant indicate that Spa2p and
Bud6p act in distinct steps in the process of polarized morphogenesis.
Interactions between Spa2p and signaling components. Spa2p interacts with Ste7p, Ste11p, Mkk1p, and Mkk2p and plays a role in cell signaling. Another putative 12S complex component, Bud6p, interacts with Ste11p. Ste7p and Mkk1p interact with Spa2p through their N-terminal putative regulatory domains. Given the similar amino acid sequences and functions of Mkk1p and Mkk2p (37), it is likely that Mkk2p interacts through this region as well. The Spa2p-interacting region of Ste7p lies within the N-terminal 136-amino-acid region, and that of Mkk1p is within its first 179 residues. However, Ste7p and Mkk1p lack obvious similarity in the primary and secondary features in these regions. It is possible that the similarity between the two MEKs occurs in a higher-order structure or through very short or degenerate sequences.
Several lines of evidence suggest that the interactions between Spa2p and MEKs are functionally important. First, deletion of SHD-I, which lies in the MEK-interacting region of Spa2p, decreases mating efficiency and results in defects in other SPA2 functions (bud site selection or proper mating projection formation) (Table 6 and data not shown). Second, expression of the portions of Mkk1p or Ste7p that interact with Spa2p from two-hybrid constructs in wild-type cells results in a higher proportion of cells unable to produce mating projections or cells producing mating projections of aberrant morphology after treatment with mating pheromone (data not shown). Third, spa2
and spa2(1-2, 116-1466)
strains have modest defects in pheromone-induced expression of a
fus2::lacZ reporter, particularly at
low pheromone concentrations (Table 7), and these cells appear to be
hyperactive for activation of the Slt2p pathway as indicated by
increased Slt2p kinase activity and hyperphosphorylation of Swi6p, a
substrate for Slt2p (Fig. 8 and 9). Thus, Spa2p may help activate the
Fus3p-Kss1p pathway and repress the Slt2p pathway. Alternatively, for
the latter case, loss of Spa2p may damage cell integrity and may
thereby activate the Slt2p pathway for compensation.
Because the defects in signaling activity are rather modest relative to
the loss in mating efficiency, it is likely that Spa2p and its
associated complex has another, as-yet-unidentified effect on the MAPK
signaling pathways. One possibility is that 12S complex components help
localize these signaling proteins to sites of polarized cell growth.
Perhaps Ste11p, Ste7p, Mkk1p, and Mkk2p are concentrated and/or
activated at growth sites, as is the case for Ste20p, which acts
upstream of Ste11p (64). Mkk1p and Mkk2p have been shown to
be important for polarized cell growth in yeast, and Ste7p and Ste11p
are important for mating and pseudohyphal growth, both of which involve
morphological changes. Localization of these different components at
growth sites may be important for their function in these processes. A
second possibility, not mutually exclusive with the first, is that the
12S complex serves as a scaffold for facilitating the interactions
among these different components. Spa2p interaction with Ste7p and
Ste11p is independent of Ste5p (Table 5). Thus, Spa2p may help mediate
interactions of the different kinases and/or prevent the kinases from
interacting with components of other MAPK pathways. Finally, Spa2p (and
Bud6p) may mediate crosstalk between two signaling pathways. For
example, it is possible that the initial response of the Slt2p pathway to the mating pheromone is through activation of Mkk1p or Mkk2p by
components of the mating pathway (Ste11p and/or Ste7p) and that Spa2p
interacts with both mating pathway signaling components and Mkk1p and
thereby facilitates this activation. Consistent with this possibility,
Zarzov et al. (94) have found that the activating tyrosine
phosphorylation of Slt2p in response to mating pheromone is delayed in
a ste11 mutant, and a similar delay can also been found in
spa2
cells (9). Moreover, deletion of
BCK1 (SLK1) still results in pheromone-induced activation of
Slt2p kinase, suggesting the existence of another upstream activator (9). Crosstalk between different MAPK pathways has recently been reported in many cases. Ste11p can function in the Hog1p pathway
by activating Pbs2p (66), and the Hog1p pathway can repress
the activity of the mating pathway (33). Perhaps Spa2p facilitates or inhibits crosstalk between components of different signaling pathways.
ACKNOWLEDGMENTS
|
|
|---|
We thank G. Sprague, E. Elion, C. Boone, and G. Paravicini for plasmids. T. Roemer, N. Burns, K. Madden, B. Manning, and Y. Barral provided critical comments on the manuscript, and D. Diener and D. Cole provided advice on the sedimentation studies.
This research was supported by grant GM36494 to M. Snyder. B. Santos was supported by a postdoctoral fellowship from the Ministerio de Educación y Ciencia, Madrid, Spain.
FOOTNOTES
* Corresponding author. Mailing address: Department of Biology, P.O. Box 208103, Yale University, New Haven, CT 06520-8103. Phone: (203) 432-6139. Fax: (203) 432-6161. E-mail: Michael.Snyder{at}yale.edu.
REFERENCES
|
|
|---|
| 1. |
Adams, A., and J. Pringle.
1984.
Relationship of actin and tubulin distribution to bud growth in wild-type and morphogenetic-mutant Saccharomyces cerevisiae.
J. Cell Biol.
98:934-945 |
| 2. | Amberg, D. C., J. E. Zahner, J. W. Mulholland, J. R. Pringle, and D. Botstein. 1997. Aip3p/Bud6p, a yeast actin-interacting protein that is involved in morphogenesis and the selection of bipolar budding sites. Mol. Biol. Cell 8:729-753[Abstract]. |
| 3. |
Arkowitz, R. A., and N. Lowe.
1997.
A small conserved domain in the yeast Spa2p is necessary and sufficient for its polarized localization.
J. Cell Biol.
138:17-36 |
| 4. |
Ayscough, K. R.,
J. Stryker,
N. Pokala,
M. Sanders,
P. Crews, and D. G. Drubin.
1997.
High rate of actin filament turnover in budding yeast and roles for actin in establishment and maintenance of cell polarity revealed using the actin inhibitor latrunculin-A.
J. Cell Biol.
137:399-416 |
| 5. |
Baudin, A.,
O. Ozier-Kalogeropoulos,
A. Denouel,
F. Lacroute, and C. Cullin.
1993.
A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae.
Nucleic Acids Res.
21:3329-3330 |
| 6. | Bedinger, P. A., K. J. Hardeman, and C. A. Loukides. 1994. Traveling in style: the cell biology of pollen. Trends Cell Biol. 4:132-138. [Medline] |
| 7. |
Bender, A., and J. R. Pringle.
1991.
Use of a screen for synthetic lethal and multicopy suppressee mutants to identify two new genes involved in morphogenesis in Saccharomyces cerevisiae.
Mol. Cell. Biol.
11:1295-1305 |
| 8. |
Brewster, J. L.,
T. D. Valoir,
N. D. Dwyer,
E. Winter, and M. C. Gustin.
1993.
An osmosensing signal transduction pathway in yeast.
Science
259:1760-1763 |
| 9. | Buehrer, B. M., and B. Errede. 1997. Coordination of the mating and cell integrity mitogen-activated protein kinase pathways in Saccharomyces cerevisiae. Mol. Cell. Biol. 17:6517-6525[Abstract]. |
| 10. |
Burns, N.,
B. Grimwade,
P. B. Ross-Macdonald,
E.-Y. Choi,
K. Finberg,
G. S. Roeder, and M. Snyder.
1994.
Large-scale characterization of gene expression, protein localization and gene disruption in Saccharomyces cerevisiae.
Genes Dev.
8:1087-1105 |
| 11. | Canter, C. R., and P. R. Schimmel. 1980. In Biophysical chemistry, part II. Techniques for the study of biological structure and function, p. 591-641. W. H. Freeman and Company, San Francisco, Calif. |
| 12. |
Chant, J., and J. R. Pringle.
1995.
Patterns of bud site selection in the yeast Saccharomyces cerevisiae.
J. Cell Biol.
129:751-765 |
| 13. | Chen, D.-C., B.-C. Yang, and T.-T. Kuo. 1992. One step-transformation of yeast in stationary phase. Curr. Genet. 21:83-84[Medline]. |
| 14. | Chenevert, J., N. Valtz, and I. Herskowitz. 1994. Identification of genes required for normal pheromone-induced cell polarization in Saccharomyces cerevisiae. Genetics 136:1287-1297[Abstract]. |
| 14a. | Choi, K.-Y., B. Satterberg, D. Lyons, and E. A. Elion. 1994. Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae. Cell 78:499-512[Medline]. |
| 15. |
Costigan, C.,
S. Gehrung, and M. Snyder.
1992.
A synthetic lethal screen identifies SLK1, a novel protein kinase homolog implicated in yeast cell morphogenesis and cell growth.
Mol. Cell. Biol.
12:1162-1178 |
| 16. |
Costigan, C.,
D. Kolodrubetz, and M. Snyder.
1994.
NHP6A and NHP6B, which encode HMG1-like proteins, function downstream in the yeast SLT2 MAPK pathway.
Mol. Cell. Biol.
14:2391-2403 |
| 17. | Costigan, C., and M. Snyder. Cell polarity in the budding yeast, Saccharomyces cerevisiae. Adv. Mol. Cell Biol., in press. |
| 18. | Drubin, D. G., H. D. Jones, and K. F. Wertman. 1993. Actin structure and function: roles in mitochondrial organization and morphogenesis in budding yeast and identification of the phalloidin-binding site. Mol. Biol. Cell 4:1277-1294[Abstract]. |
| 19. | Drubin, D. G., and W. J. Nelson. 1996. Origins of cell polarity. Cell 84:335-344[Medline]. |
| 20. | Eisen, J. S. 1994. Development of motoneuronal phenotype. Annu. Rev. Neurol. 17:1-30. |
| 21. | Elion, E. A., P. L. Grisafi, and G. R. Fink. 1990. FUS3 encodes a cdc2+/CDC28-related kinase required for the transition from mitosis into conjugation. Cell 60:649-664[Medline]. |
| 22. | Elion, E. A., B. Satterberg, and J. E. Kranz. 1993. FUS3 phosphorylates multiple components of the mating signaling transduction cascade: evidence for STE12 and FAR1. Mol. Biol. Cell 4:495-510[Abstract]. |
| 22a. | Elledge, S. J. Personal communication. |
| 23. |
Erdman, S.,
L. Lin,
M. Malczynski, and M. Snyder.
1998.
Pheromone-regulated genes required for yeast mating differentiation.
J. Cell Biol.
140:461-483 |
| 24. | Errede, B., R. M. Cade, B. M. Yasar, Y. Kamada, D. E. Levin, K. Irie, and K. Matsumoto. 1995. Dynamics and organization of MAP kinase signal pathways. Mol. Reprod. Dev. 42:477-485[Medline]. |
| 25. | Errede, B., A. Gartner, Z. Zhou, K. Nasmyth, and G. Ammerer. 1993. MAP kinase-related FUS3 from S. cerevisiae is activated by STE7 in vitro. Nature 362:261-264[Medline]. |
| 26. |
Evangelista, M.,
K. Blundell,
M. S. Longtine,
C. J. Chow,
N. Adames,
J. R. Pringle,
M. Peter, and C. Boone.
1997.
Bni1p, a yeast formin linking Cdc42p and the actin cytoskeleton during polarized morphogenesis.
Science
276:118-122 |
| 27. | Fields, S., and O.-K. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246[Medline]. |
| 27a. |
Flescher, E. G.,
K. Madden, and M. Snyder.
1993.
Components required for cytokinesis are important for bud site selection in yeast.
J. Cell Biol.
122:373-386 |
| 28. | Freifelder, D. 1960. Bud position in Saccharomyces cerevisiae. J. Bacteriol. 124:511-523. |
| 29. |
Gartner, A.,
K. Nasmyth, and G. Ammerer.
1992.
Signal transduction in Saccharomyces cerevisiae requires tyrosine and threonine phosphorylation of FUS3 and KSS1.
Genes Dev.
6:1280-1292 |
| 30. |
Gehrung, S., and M. Snyder.
1990.
The SPA2 gene of Saccharomyces cerevisiae is important for pheromone-induced morphogenesis and efficient mating.
J. Cell Biol.
111:1451-1464 |
| 31. | Gimeno, C. J., P. O. Ljungdahl, C. A. Styles, and G. R. Fink. 1992. Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: regulation by starvation and RAS. Cell 68:1077-1090[Medline]. |
| 32. |
Golemis, E. A., and R. Brent.
1992.
Fused protein domains inhibit DNA binding by LexA.
Mol. Cell. Biol.
12:3006-3014 |
| 33. | Hall, J. P., V. Cherkasova, E. Elion, M. C. Guitin, and E. Winter. 1996. The osmoregulatory pathway represses mating pathway activity in Saccharomyces cerevisiae: isolation of a FUS3 mutant that is insensitive to the repression mechanism. Mol. Cell. Biol. 16:6715-6723[Abstract]. |
| 34. | Harlow, E., and D. Lane. 1988. In Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 35. | Herskowitz, I. 1995. MAP kinase pathways in yeast: for mating and more. Cell 80:187-197[Medline]. |
| 36. |
Hicks, J. B.,
J. N. Strathern, and I. Herskowitz.
1977.
Interconversion of yeast mating types. III. Action of the homothallism (HO) gene in cells homozygous for the mating type locus.
Genetics
85:395-405 |
| 37. |
Irie, K.,
M. Takase,
K. Lee,
D. Levin,
H. Araki,
K. Matsumoto, and Y. Oshima.
1993.
MKK1 and MKK2, which encode Saccharomyces cerevisiae mitogen-activated protein kinase-kinase homologs, function in the pathway mediated by protein kinase C.
Mol. Cell. Biol.
13:3076-3083 |
| 38. |
Ito, H.,
Y. Fukuda,
K. Murata, and A. Kimura.
1983.
Transformation of intact yeast cells treated with alkali cations.
J. Bacteriol.
153:163-168 |
| 39. |
Johnson, D. I., and J. R. Pringle.
1990.
Molecular characterization of CDC42, a Saccharomyces cerevisiae gene involved in the development of cell polarity.
J. Cell Biol.
111:143-152 |
| 40. |
Kamada, Y.,
U. S. Jung,
J. Piotrowski, and D. E. Levin.
1995.
The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response.
Genes Dev.
9:1559-1571 |
| 41. |
Kilmartin, J. V., and A. E. M. Adams.
1984.
Structural rearrangements of tubulin and actin during the cell cycle of the yeast Saccharomyces.
J. Cell Biol.
98:922-933 |
| 42. |
Kilmartin, J. V.,
S. L. Dyos,
D. Kershaw, and J. T. Finch.
1993.
A spacer protein in the Saccharomyces cerevisiae spindle pole body whose transcript is cell cycle regulated.
J. Cell Biol.
123:1175-1184 |
| 43. |
Leberer, E.,
D. Dignard,
D. Harcus,
D. Y. Thomas, and M. Whiteway.
1992.
The protein kinase homologue STE20p is required to link the yeast pheromone response G-protein ![]() subunits to downstream signalling components.
EMBO J.
11:4815-4824[Medline].
|
| 44. |
Lee, K., and D. Levin.
1992.
Dominant mutations in a gene encoding a putative protein kinase (BCK1) bypass the requirement for a Saccharomyces cerevisiae protein kinase C homolog.
Mol. Cell. Biol.
12:172-182 |
| 45. | Levin, D., and B. Errede. 1993. A multitude of MAP kinase activation pathways. J. NIH Res. 5:49-52. |
| 46. | Levin, D. E., and B. Errede. 1995. The proliferation of MAP kinase signaling pathways in yeast. Curr. Opin. Cell Biol. 7:197-202[Medline]. |
| 47. |
Lew, D. J., and S. I. Reed.
1993.
Morphogenesis in the yeast cell cycle: regulation by Cdc28 and cyclins.
J. Cell Biol.
120:1305-1320 |
| 48. |
Liu, H.,
C. A. Styles, and G. R. Fink.
1993.
Elements of the yeast pheromone response pathway required for filamentous growth of diploids.
Science
262:1741-1744 |
| 49. |
Madden, K.,
Y.-J. Sheu,
K. Baetz,
B. Andrews, and M. Snyder.
1997.
SBF cell cycle regulator as a target of the yeast SLT2 MAP kinase pathway.
Science
275:1781-1784 |
| 50. | Madden, K., and M. Snyder. 1992. Specification of sites of polarized growth in Saccharomyces cerevisiae and the influence of external factors on site selection. Mol. Biol. Cell 3:1025-1035[Abstract]. |
| 51. | Madhani, H. D., C. A. Styles, and G. R. Fink. 1997. MAP kinases with distinct inhibitory function impart signaling specificity during yeast differentiation. Cell 91:673-684[Medline]. |
| 52. | Marshall, C. J. 1994. MAP kinase kinase kinase, MAP kinase kinase, and MAP kinase. Curr. Opin. Genet. Dev. 4:82-89[Medline]. |
| 53. |
Mazzoni, C.,
P. Zarzov,
A. Rambourg, and C. Mann.
1993.
The SLT2 (MPK1) MAP kinase homolog is involved in polarized cell growth in Saccharomyces cerevisiae.
J. Cell Biol.
123:1821-1833 |
| 54. | Meluh, P. B., and M. D. Rose. 1990. KAR3, a kinesin-related gene required for yeast nuclear fusion. Cell 60:1029-1941[Medline]. |
| 55. |
Mirzayan, C.,
C. Copeland, and M. Snyder.
1992.
The NUF1 gene encodes a coiled-coil related protein that is a potential component of the yeast nucleoskeleton.
J. Cell Biol.
116:1319-1332 |
| 56. | Mooseker, M. S. 1985. Organization, chemistry, and assembly of the cytoskeletal apparatus of the intestinal brush border. Annu. Rev. Cell Biol. 1:209-241. |
| 57. | Mosch, H.-U., and G. R. Fink. 1997. Dissection of filamentous growth by transposon mutagenesis in Saccharomyces cerevisiae. Genetics 145:671-684[Abstract]. |
| 58. |
Mulholland, J.,
D. Preuss,
A. Moon,
A. Wong,
D. Drubin, and D. Botstein.
1994.
Ultrastructure of the yeast actin cytoskeleton and its association with the plasma membrane.
J. Cell Biol.
125:381-391 |
| 59. |
Neiman, A. M., and I. Herskowitz.
1994.
Reconstitution of a yeast protein kinase cascade in vitro: activation of the yeast MEK homologue STE7 by STE11.
Proc. Natl. Acad. Sci. USA
91:3398-3402 |
| 60. | Novick, P., and D. Botstein. 1985. Phenotypic analysis of temperature-sensitive yeast actin mutants. Cell 40:405-416[Medline]. |
| 61. |
Ohya, Y.,
S. Miyamoto,
Y. Ohsumi, and Y. Anraku.
1986.
Calcium-sensitive cls4 mutant of Saccharomyces cerevisiae with a defect in bud formation.
J. Bacteriol.
165:28-33 |
| 62. |
Page, B. D.,
L. L. Satterwhite,
M. D. Rose, and M. Snyder.
1994.
Localization of the KAR3 kinesin heavy chain-like protein requires the CIK1 interacting protein.
J. Cell Biol.
124:507-519 |
| 63. |
Page, B. D., and M. Snyder.
1992.
CIK1: a developmentally regulated spindle pole body-associated protein important for microtubule functions in Saccharomyces cerevisiae.
Genes Dev.
6:1414-1429 |
| 64. | Peter, M., A. M. Neiman, H.-O. Park, M. van Lohuizen, and I. Herskowitz. 1996. Functional analysis of the interaction between the small GTP binding protein Cdc42 and the Ste20 protein kinase in yeast. EMBO. 15:7046-7059[Medline]. |
| 65. |
Peterson, J.,
Y. Zheng,
L. Bender,
A. Myers,
R. Cerione, and A. Bender.
1994.
Interactions between the bud emergence proteins Bem1p and Bem2p and Rho-type GTPases in yeast.
J. Cell Biol.
127:1395-1406 |
| 66. |
Posas, F., and H. Saito.
1997.
Osmotic activation of the HOG MAPK pathway via Ste11p MAPKKK: scaffold role of Pbs2p MAPKK.
Science
276:1702-1705 |
| 67. |
Pringle, J.,
E. Bi,
H. Harkins,
J. Zahner,
C. Devirgilio,
J. Chant,
K. Corado, and H. Fares.
1995.
Establishment of cell polarity in yeast.
Cold Spring Harbor Symp. Quant. Biol.
60:729-744 |
| 67a. | Printen, J. A., and G. F. Sprague, Jr. 1994. Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade. Genetics 138:609-619[Abstract]. |
| 68. | Read, E. B., H. H. Okamura, and D. G. Drubin. 1992. Actin- and tubulin-dependent functions during Saccharomyces cerevisiae mating projection formation. Mol. Biol. Cell 3:429-444[Abstract]. |
| 69. |
Roberts, R., and G. R. Fink.
1994.
Elements of a single MAP kinase cascade in Saccharomyces cerevisiae mediate two developmental programs in the same cell type: mating and invasive growth.
Genes Dev.
8:2974-2985 |
| 70. |
Roemer, T.,
K. Madden,
J. Chang, and M. Snyder.
1996.
Selection of axial growth sites in yeast requires Axl2p, a novel plasma membrane glycoprotein.
Genes Dev.
10:777-793 |
| 71. | Roemer, T., L. Vallier, Y.-J. Sheu, and M. Snyder. 1998. The Spa2-related protein, Sph1, is important for polarized growth in yeast. J. Cell Sci. 111:479-494[Abstract]. |
| 72. | Roemer, T., L. Vallier, and M. Snyder. 1996. Selection of polarized growth sites in yeast. Trends Cell Biol. 6:434-441. |
| 73. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. In Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 74. |
Santos, B., and M. Snyder.
1997.
Targeting of chitin synthase 3 to polarized growth sites in yeast requires Chs5p and Myo2p.
J. Cell Biol.
136:95-110 |
| 75. |
Scherr, G. H., and R. H. Weaver.
1953.
The dimorphism phenomenon in yeasts.
Bacteriol. Rev.
17:51-92 |
| 76. | Schneider, B. L., W. Seufert, B. Steiner, Q. H. Yang, and A. B. Futcher. 1995. Use of PCR epitope tagging for protein tagging in Saccharomyces cerevisiae. Yeast 11:1265-1274[Medline]. |
| 77. | Sherman, F., G. Fink, and J. Hicks. 1986. In Methods in yeast genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 78. |
Sikorski, R., and P. Hieter.
1989.
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics
122:19-27 |
| 79. |
Sloat, B., and J. Pringle.
1978.
A mutant of yeast defective in cellular morphogenesis.
Science
200:1171-1173 |
| 80. |
Snyder, M.
1989.
The SPA2 protein of yeast localizes to sites of cell growth.
J. Cell Biol.
108:1419-1429 |
| 81. |
Snyder, M.,
S. Gehrung, and B. D. Page.
1991.
Studies concerning the temporal and genetic control of cell polarity in Saccharomyces cerevisiae.
J. Cell Biol.
114:515-532 |
| 81a. | Sobel, S., S. McPherson, and M. Snyder. Unpublished data. |
| 82. | Sprague, G. F., and J. Thorner. 1992. Pheromone response and signal transduction during the mating process of Saccharomyces cerevisiae, p. 657-744. In E. W. Jones, J. R. Pringle, and J. R. Broach (ed.), The molecular and cellular biology of the yeast Saccharomyces. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 83. |
Stevenson, B. J.,
N. Rhodes,
B. Errede, and G. F. Sprague.
1992.
Constitutive mutants of the protein kinase STE11 activate the yeast pheromone response pathway in the absence of G protein.
Genes Dev.
6:1293-1304 |
| 84. | Torres, L., H. Martin, M. I. Garcia-Saez, J. Arroyo, M. Molina, M. Sanchez, and C. Nombela. 1991. A protein kinase gene complements the lytic phenotype of Saccharomyces cerevisiae lyt2 mutants. Mol. Microbiol. 5:2845-2854[Medline]. |
| 85. | Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215[Medline]. |
| 86. |
Valtz, N., and I. Herskowitz.
1996.
Pea2 protein of yeast is localized to sites of polarized growth and is required for efficient mating and bipolar budding.
J. Cell Biol.
135:725-739 |
| 87. |
Valtz, N.,
M. Peter, and I. Herskowitz.
1995.
FAR1 is required for oriented polarization of yeast cells in response to mating pheromones.
J. Cell Biol.
131:863-873 |
| 88. | Wertman, K. F., D. G. Drubin, and D. Botstein. 1992. Systematic mutational analysis of the yeast ACT1 gene. Genetics 132:337-350[Abstract]. |
| 89. |
Xie, K.,
E. Lambie, and M. Snyder.
1993.
Nuclear dot antigens may specify transcriptional domains in the nucleus.
Mol. Cell. Biol.
13:6170-6179 |
| 90. |
Yang, C. H.,
E. J. Lambie, and M. Snyder.
1992.
NuMA: an unusually large coiled-coil protein in the mammalian nucleus.
J. Cell Biol.
116:1303-1317 |
| 91. |
Yang, S.,
K. R. Ayscough, and D. G. Drubin.
1997.
A role for the actin cytoskeleton of Saccharomyces cerevisiae in bipolar bud-site selection.
J. Cell Biol.
136:111-123 |
| 92. |
Yorihuzi, T., and Y. Ohsumi.
1994.
Saccharomyces cerevisiae MAT mutant cells defective in pointed projection formation in response to -factor at high concentrations.
Yeast
10:579-594[Medline].
|
| 93. | Zahner, J. E., H. A. Harkins, and J. R. Pringle. 1996. Genetic analysis of the bipolar pattern of bud site selection in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 16:1857-1870[Abstract]. |
| 94. | Zarzov, P., C. Mazzoni, and C. Mann. 1996. The SLT2 (MPK1) MAP kinase is activated during periods of polarized cell growth in yeast. EMBO. 15:83-91[Medline]. |
| 95. |
Zhou, Z.,
A. Gartner,
R. Cade,
G. Ammerer, and B. Errede.
1993.
Pheromone-induced signal transduction in Saccharomyces cerevisiae requires the sequential function of three protein kinases.
Mol. Cell. Biol.
13:2069-2080 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»